iBET Highlights Biomanufacturing Innovation at Portugal–Japan Life Sciences Forum
iBET’s vision for bioprocessing and translational R&D presented in AICEP meeting in Tokyo
On July 1st, iBET had the honor of participating in the Portugal – Japan Life Sciences Forum at the Portuguese Embassy in Tokyo, organized by AICEP as part of Portugal’s economic diplomacy program in Japan.
Representing iBET, our Chief Technical Operations Officer Pedro Cruz joined a distinguished panel alongside leaders from NTT Data Portugal, Hovione, and the University of Coimbra, to discuss innovation and sustainability in healthcare. The presentation focused on iBET’s integrated approach to advanced biomanufacturing and translational R&D, showcasing our capabilities in biologics, cell and gene therapies, and digital bioprocessing.
This event took place just over 25-years after iBET’s first collaboration with Japanese companies, which began in the late 1990’s with Yamanouchi—now Astellas. Over the years, we’ve built trusted partnerships with other institutions like Asahi Kasei, Sumitomo Pharma, and Ehime University, advancing joint R&D in advanced therapies, vaccines, analytics, and bioprocess innovation.
We thank AICEP and the Portuguese Embassy in Tokyo for the opportunity to share our vision and connect with forward-thinking Japanese stakeholders. We look forward to deepening these ties and remain deeply committed to expanding our collaborations with Japanese companies to accelerate the development of next generation biopharmaceuticals.
